Print Page   |   Sign In   |   Create a Profile
News & Press: Industry News

Intent Solutions™ Well Positioned to Address U.S. Opioid Crisis

Tuesday, October 17, 2017   (0 Comments)
Posted by: Kristen Pappaterra
Share |
ATLANTA (Oct. 17, 2017) — Intent Solutions™, creator of the breakthrough medical device technology, TAD™, has rounded out its executive team in preparation for going commercial later this year, which puts the company in a promising position to address the ongoing national opioid crisis. The commercialization efforts follow the company’s successful $1.5 million seed round capital raise in 2016 and an additional $1.5M in 2017.

“Even with great doctors and groundbreaking medications, patient results will be ineffective if they don’t take their medication as directed,” said Sam Zamarripa, Intent Solutions CEO. “We have a mission inside healthcare and research — we’re looking to alter the very definition of what it means to be adherent.”

In addition to helping address the national opioid crisis as reported by the Atlanta Journal Constitution, the medication dispenser helps facilitate clinical trials with its ability to record adherence data, which is sent to a cloud database for analysis, reducing errors and simplifying data reconciliation.

Since his promotion to CEO from his previous post as president, Zamarripa has led the development of Intent Solutions’ market strategy, helped to attract serious investments, and hired experienced executives to complete its management team, giving the company an edge as it looks to go commercial.

“The board’s mandate to me is to grow the company and successfully take it to market,” Zamarripa said. “With the addition of new key executive members, Intent Solutions is poised for commercial success in the areas of addiction, pain treatment, clinical trials, and beyond.”

Recent staff additions include:
Ward Broom, chief operating officer: Broom co-founded a healthcare business and has experience in taking a product from development to an exit. Broom has two degrees from the Georgia Institute of Technology and is currently completing his MBA with a focus in management of technology.
Paul Quiner, chief strategy officer and general counsel: Having spent his entire career in healthcare, both on the law and business development sides, Quiner most recently oversaw acquisitions for his former employer, McKesson, a Fortune 5 company. He brings a unique perspective on regulatory issues and overall strategy. His role with Intent Solutions will include helping to prioritize all the opportunities the company has in healthcare, putting together a solid strategy for success.

With the new energy and expertise of its additional hires, Intent Solutions is pushing into the final frontier of medicine. Knowing the need for a solution in addition and clinical trials, the company also is studying other markets including oncology drugs, specialty pharma, chronic pain, and tracking medication for adolescents and the elderly.
For more information on Intent Solutions or the TAD device, visit or contact

About Intent Solutions:
Headquartered in Atlanta, Georgia, Intent Solutions is a technology, software, and data service company focused on developing solutions for clinical research, pain management, and specialized pharmacy. Its products markedly improve the monitoring and management of medication adherence and provide real time behavioral data to more accurately measure compliance and efficacy. For more information, visit:

more Calendar

SEMDA/GaBio Joint Quarterly Meeting

Membership Software Powered by YourMembership  ::  Legal